PHREESIA ($PHR) posted quarterly earnings results on Wednesday, May 28th. The company reported earnings of -$0.07 per share, beating estimates of -$0.12 by $0.05. The company also reported revenue of $115,940,000, missing estimates of $116,143,940 by $-203,940.
You can see Quiver Quantitative's $PHR stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
PHREESIA Insider Trading Activity
PHREESIA insiders have traded $PHR stock on the open market 97 times in the past 6 months. Of those trades, 0 have been purchases and 97 have been sales.
Here’s a breakdown of recent trading of $PHR stock by insiders over the last 6 months:
- EVAN ROBERTS (Chief Operating Officer) has made 0 purchases and 16 sales selling 95,488 shares for an estimated $2,557,648.
- CHAIM INDIG (Chief Executive Officer) has made 0 purchases and 8 sales selling 71,563 shares for an estimated $1,901,106.
- BALAJI GANDHI (Chief Financial Officer) has made 0 purchases and 13 sales selling 64,922 shares for an estimated $1,847,701.
- DAVID LINETSKY (SVP, Life Sciences) has made 0 purchases and 21 sales selling 64,697 shares for an estimated $1,736,033.
- ALLISON C HOFFMAN (General Counsel & Secretary) has made 0 purchases and 14 sales selling 52,204 shares for an estimated $1,378,246.
- MICHAEL WEINTRAUB has made 0 purchases and 4 sales selling 55,152 shares for an estimated $1,321,348.
- AMY BETH VANDUYN (SVP, Human Resources) has made 0 purchases and 9 sales selling 37,876 shares for an estimated $863,409.
- YVONNE HUI (Principal Accounting Officer) has made 0 purchases and 12 sales selling 9,281 shares for an estimated $223,938.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
PHREESIA Hedge Fund Activity
We have seen 120 institutional investors add shares of PHREESIA stock to their portfolio, and 98 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BROWN ADVISORY INC removed 1,824,110 shares (-32.6%) from their portfolio in Q1 2025, for an estimated $46,624,251
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 1,377,904 shares (+108.7%) to their portfolio in Q1 2025, for an estimated $35,219,226
- AMERICAN CENTURY COMPANIES INC added 957,842 shares (+3741.9%) to their portfolio in Q1 2025, for an estimated $24,482,441
- ROCK SPRINGS CAPITAL MANAGEMENT LP removed 891,664 shares (-43.7%) from their portfolio in Q1 2025, for an estimated $22,790,931
- TIMESSQUARE CAPITAL MANAGEMENT, LLC removed 868,409 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $21,849,170
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 594,825 shares (-66.6%) from their portfolio in Q1 2025, for an estimated $15,203,727
- CHAMPLAIN INVESTMENT PARTNERS, LLC added 490,340 shares (+20.0%) to their portfolio in Q1 2025, for an estimated $12,533,090
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
PHREESIA Analyst Ratings
Wall Street analysts have issued reports on $PHR in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 01/10/2025
- KeyBanc issued a "Overweight" rating on 01/08/2025
To track analyst ratings and price targets for PHREESIA, check out Quiver Quantitative's $PHR forecast page.
PHREESIA Price Targets
Multiple analysts have issued price targets for $PHR recently. We have seen 2 analysts offer price targets for $PHR in the last 6 months, with a median target of $31.0.
Here are some recent targets:
- Joe Vruwink from Robert W. Baird set a target price of $30.0 on 12/11/2024
- Gil Luria from D.A. Davidson set a target price of $32.0 on 11/29/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
